Cargando…
Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
by the AGA Institute
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256492/ https://www.ncbi.nlm.nih.gov/pubmed/32479824 http://dx.doi.org/10.1053/j.gastro.2020.05.066 |
| _version_ | 1783539921099685888 |
|---|---|
| author | Lukin, Dana J. Kumar, Anand Hajifathalian, Kaveh Sharaiha, Reem Z. Scherl, Ellen J. Longman, Randy S. |
| author_facet | Lukin, Dana J. Kumar, Anand Hajifathalian, Kaveh Sharaiha, Reem Z. Scherl, Ellen J. Longman, Randy S. |
| author_sort | Lukin, Dana J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7256492 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | by the AGA Institute |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72564922020-05-29 Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease Lukin, Dana J. Kumar, Anand Hajifathalian, Kaveh Sharaiha, Reem Z. Scherl, Ellen J. Longman, Randy S. Gastroenterology Brief Communication by the AGA Institute 2020-10 2020-05-29 /pmc/articles/PMC7256492/ /pubmed/32479824 http://dx.doi.org/10.1053/j.gastro.2020.05.066 Text en © 2020 by the AGA Institute. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Brief Communication Lukin, Dana J. Kumar, Anand Hajifathalian, Kaveh Sharaiha, Reem Z. Scherl, Ellen J. Longman, Randy S. Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease |
| title | Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease |
| title_full | Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease |
| title_fullStr | Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease |
| title_full_unstemmed | Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease |
| title_short | Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease |
| title_sort | baseline disease activity and steroid therapy stratify risk of covid-19 in patients with inflammatory bowel disease |
| topic | Brief Communication |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256492/ https://www.ncbi.nlm.nih.gov/pubmed/32479824 http://dx.doi.org/10.1053/j.gastro.2020.05.066 |
| work_keys_str_mv | AT lukindanaj baselinediseaseactivityandsteroidtherapystratifyriskofcovid19inpatientswithinflammatoryboweldisease AT kumaranand baselinediseaseactivityandsteroidtherapystratifyriskofcovid19inpatientswithinflammatoryboweldisease AT hajifathaliankaveh baselinediseaseactivityandsteroidtherapystratifyriskofcovid19inpatientswithinflammatoryboweldisease AT sharaihareemz baselinediseaseactivityandsteroidtherapystratifyriskofcovid19inpatientswithinflammatoryboweldisease AT scherlellenj baselinediseaseactivityandsteroidtherapystratifyriskofcovid19inpatientswithinflammatoryboweldisease AT longmanrandys baselinediseaseactivityandsteroidtherapystratifyriskofcovid19inpatientswithinflammatoryboweldisease AT baselinediseaseactivityandsteroidtherapystratifyriskofcovid19inpatientswithinflammatoryboweldisease AT baselinediseaseactivityandsteroidtherapystratifyriskofcovid19inpatientswithinflammatoryboweldisease |